查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1842244

美國獸醫眼科市場：市場規模、佔有率和趨勢分析（按動物、產品、適應症和分銷管道分類），細分市場預測（2025-2033 年）

U.S. Veterinary Eye Care Market Size, Share & Trends Analysis Report By Animal (Canine, Feline, Equine, Bovine), By Product (Devices & Instruments, Medications), By Indication, By Distribution Channel, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

美國獸醫眼科市場概覽

據估計，2024 年美國獸醫眼科市值為 16.6 億美元，預計到 2033 年將達到 27.1 億美元，2025 年至 2033 年的複合年成長率為 5.6%。

推動這一市場發展的因素包括動物眼科護理途徑的擴展、對合理使用抗生素的日益倡導、獸醫專業人員更多地參與宣傳推廣以及動物眼科護理技術的進步。

在美國，獸醫眼科領域正經歷顯著成長，這得益於外科技術、基因研究和診斷技術的進步。這些發展正在擴大獸醫眼科的診療範圍，並為曾經被認為無法治癒的疾病帶來新的希望。

一個值得注意的例子是，2025年1月在加州大學戴維斯分校進行的一項手術，該手術採用視網膜復位術（視網膜固定術）治療犬類視網膜裂孔。手術方法是將眼內的天然凝膠替換為矽油，從而將視網膜復位，有效恢復患者的視力。由於手術設備和培訓的改進，這種專業手術正變得越來越普及。

基因研究在獸醫眼科學中也扮演著至關重要的角色。例如，dvm360 於 2025 年 3 月發表的一項研究已經確定了導致犬隻進行性視網膜萎縮 (PRA) 等疾病的特定基因突變。例如，GTPBP2 基因中三個鹼基對的缺失與 PRA 相關，這為基因檢測和基於基因的育種決策提供了基礎。這種方法旨在防止此類疾病的遺傳，從而降低其在後代中的盛行率。

就治療方案而言，拉坦前列素在貓青光眼治療的應用凸顯了獸醫眼科學的複雜性。雖然拉坦前列素能有效降低貓的眼內壓，但其局限性也表明，需要繼續研究和開發更適合貓生理特徵的更有效的治療方法。

此外，採用雷射技術治療犬類眼瞼腫瘤代表非侵入性外科技術的重大進步。根據dvm360網站2025年3月發表的一篇報導報道，與傳統方法相比，雷射治療具有更高的精準度和更快的恢復速度，從而改善了寵物和飼主的整體治療體驗。

這些以及其他創新推動了獸醫眼科學領域的蓬勃發展和快速進步。隨著該領域的不斷進步，預計它將反映出獸醫護理專業化、人性化這一更廣泛的趨勢，並改善患有各種眼科疾病的動物的治療效果。

目錄

第1章 分析方法和範圍

第2章執行摘要

第3章美國動物眼科市場：促進因素、趨勢與範圍

  • 市場關聯性展望
    • 母市場
    • 附隨市場
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
    • 產業分析
    • 定價分析
    • 主要品種動物數量估算（2021-2024 年）

第4章：美國動物眼科市場：依動物類型分類的估算與趨勢分析

  • 細分儀表板
  • 美國獸醫眼科市場：按物種分類的變化分析
  • 美國獸醫眼科市場規模及趨勢分析（按物種分類）（2021-2033 年）
  • 犬齒
  • 貓科動物
  • 馬
  • 牛
  • 其他動物

第5章：美國動物眼科市場：依產品分類的估算與趨勢分析

  • 細分儀表板
  • 美國獸醫眼科市場：按產品分類的變化分析
  • 美國獸醫眼科市場規模及產品趨勢分析（2021-2033）
  • 設備和器材
  • 治療設備
  • 製藥
    • 2021-2033年醫藥產業收入估算與預測
    • 抗生素
    • NSAID
    • 皮質類固醇
    • 潤滑劑/人工淚液
    • 止痛藥
    • 其他藥物

第6章：美國動物眼科市場：依適應症分類的估算與趨勢分析

  • 細分儀表板
  • 美國獸醫眼科市場：依適應症分類的變化分析
  • 美國獸醫眼科市場規模及趨勢分析（依適應症分類）（2021-2033 年）
    • 眼瞼異常
    • 白內障
    • 青光眼
    • 葡萄膜炎
    • 結膜炎
    • 角膜併發症
    • 其他跡象

第7章：美國動物眼科市場：按分銷管道分類的估算和趨勢分析

  • 細分儀表板
  • 美國獸醫眼科市場：按通路分類的變化分析
  • 美國獸醫眼科市場規模及趨勢分析（按分銷管道分類）（2021-2033 年）
    • 獸醫醫院和診所
    • 專賣店
    • 電子商務
    • 其他分銷管道

第8章 競爭情勢

  • 市場參與企業分類
  • 企業市場分析/熱力圖分析
  • 公司簡介
    • Merck &Co., Inc.
    • An-Vision GmbH
    • Jorgensen Laboratories
    • LKC Technologies Inc.
    • Accutome Inc.
    • Dechra
    • Bausch &Lomb Incorporated
    • Zoetis Services LLC.
    • Ceva Sante Animale
    • Sandoz
    • Boehringer Ingelheim
    • I-Med Animal Health
    • Iridex Corporation
    • Baxter（Welch Allyn）
    • OptoMed
    • Reichert, Inc.
    • Occuity
    • Strategy Mapping
    • Mergers &Acquisitions
    • Partnerships &Collaborations
    • Product launch
    • Others
  • 其他主要企業名單
Product Code: GVR-4-68040-724-2

U.S. Veterinary Eye Care Market Summary

The U.S. veterinary eye care market size was estimated at USD 1.66 billion in 2024 and is projected to reach USD 2.71 billion by 2033, growing at a CAGR of 5.6% from 2025 to 2033. The market is advancing owing to factors such as expanding veterinary eye care avenues, increasing advocacy for rationale use of antibiotics, growing involvement of veterinary professionals in spreading awareness, and technological advancements in veterinary eye care.

The veterinary eye care sector in the U.S. is experiencing significant growth, driven by advancements in surgical techniques, genetic research, and diagnostic technologies. These developments are expanding the scope of eye care for animals, offering new hope for conditions that were once considered untreatable.

A notable example is the use of retinal reattachment surgery, or retinopexy, conducted in January 2025, by UC Davis, to address retinal tears in dogs. This procedure involves replacing the natural gel in the eye with silicone oil to reposition the retina, effectively restoring vision in affected animals. Such specialized surgeries are becoming more accessible, thanks to improvements in surgical equipment and training.

Genetic research is also playing a pivotal role in veterinary eye care. Studies such as the March 2025 article published by dvm360 have identified specific genetic mutations responsible for conditions such as progressive retinal atrophy (PRA) in dogs. For instance, a 3-base pair deletion in the GTPBP2 gene has been linked to PRA, providing a basis for genetic testing and informed breeding decisions. This approach aims to prevent the hereditary transmission of such conditions, thereby reducing their prevalence in future generations.

In terms of treatment options, the use of latanoprost in managing glaucoma in cats highlights the complexities of veterinary ophthalmology. While latanoprost has shown efficacy in lowering intraocular pressure in cats, its limitations underscore the need for ongoing research and development of more effective therapies tailored to feline physiology.

Furthermore, the adoption of laser technology for treating canine eyelid tumors represents a significant advancement in non-invasive surgical techniques. As per March 2025 article published by dvm360, laser treatments offer precision and reduced recovery times compared to traditional methods, enhancing the overall treatment experience for both pets and their owners.

Collectively, these innovations are contributing to a dynamic and rapidly evolving veterinary ophthalmology landscape. As the field continues to progress, it holds the promise of improved outcomes for animals suffering from a range of ocular conditions, reflecting a broader trend toward specialized and compassionate veterinary care.

U.S. Veterinary Eye Care Market Report Segmentation

This report forecasts revenue growth at country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. veterinary eye care market report based on animal, product, indication, and distribution channel:

  • Animal Outlook (Revenue, USD Million, 2021 - 2033)
  • Canine
  • Feline
  • Equine
  • Bovine
  • Others
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Devices & Instruments
    • Diagnostic Devices
    • Tonometers
    • Ophthalmic Test Kits
    • Electroretinogram (ERG)
    • Fundus Camera
    • Ophthalmoscopes
    • Pachymeter
    • Other Diagnostic Devices
    • Treatment Devices
    • Lenses
    • Bandage Lenses
    • Intraocular Lenses
    • Laser Devices
    • Other Treatment Devices
  • Medications
    • Antibiotics
    • NSAIDs
    • Corticosteroids
    • Lubricants / Artificial Tears
    • Analgesics / Pain Relievers
    • Other Medications
  • Indication Outlook (Revenue, USD Million, 2021 - 2033)
  • Eyelid Abnormalities
  • Cataract
  • Glaucoma
  • Retinal Complications
  • Uveitis
  • Conjunctivitis
  • Corneal Complications
  • Other Indications
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Veterinary Hospitals & Clinics
  • Specialty Stores
  • E-Commerce
  • Other Distribution Channels

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
  • 1.4. Information/Data Analysis
  • 1.5. Market Formulation & Visualization
  • 1.6. Data Validation & Publishing
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis
    • 1.7.2. Country Market: CAGR Calculation
  • 1.8. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Veterinary Eye Care Market Variable Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market
    • 3.1.2. Ancillary Market
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Expanding Veterinary Eye Care Avenues
      • 3.2.1.2. Increasing Advocacy for Rationale Use of Antibiotics
      • 3.2.1.3. Growing Involvement of Veterinary Professionals in Spreading Awareness
      • 3.2.1.4. Technological Advancements in Veterinary Eye Care
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Cost Of Veterinary Ophthalmic Procedures
      • 3.2.2.2. Limitations of Medications in Ophthalmology Care
    • 3.2.3. Market Opportunity Analysis
    • 3.2.4. Market Challenge Analysis
    • 3.2.5. Industry Analysis
      • 3.2.5.1. Porter's Five Forces Analysis
      • 3.2.5.2. PESTLE by SWOT Analysis
    • 3.2.6. Pricing Analysis
    • 3.2.7. Estimated Animal Population by key species, 2021 - 2024

Chapter 4. U.S. Veterinary Eye Care Market: Animal Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Veterinary Eye Care Market: Animal Movement Analysis
  • 4.3. U.S. Veterinary Eye Care Market Size & Trend Analysis, by animal, 2021 to 2033 (USD Million)
  • 4.4. Canine
    • 4.4.1. Canine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Feline
    • 4.5.1. Feline Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Equine
    • 4.6.1. Equine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Bovine
    • 4.7.1. Bovine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Other Animals
    • 4.8.1. Other Animals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Veterinary Eye Care Market: Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Veterinary Eye Care Market: Product Movement Analysis
  • 5.3. U.S. Veterinary Eye Care Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 5.4. Devices & Instruments
    • 5.4.1. Devices & Instruments Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.4.1.1. Diagnostic Devices
        • 5.4.1.1.1. Diagnostic Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.4.1.2. Tonometers
        • 5.4.1.2.1. Tonometers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.4.1.3. Ophthalmic Test Kits
        • 5.4.1.3.1. Ophthalmic Test Kits Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.4.1.4. Electroretinogram (ERG)
        • 5.4.1.4.1. Electroretinogram (ERG) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.4.1.5. Fundus Camera
        • 5.4.1.5.1. Fundus Camera Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.4.1.6. Ophthalmoscopes
        • 5.4.1.6.1. Ophthalmoscopes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.4.1.7. Pachymeter
        • 5.4.1.7.1. Pachymeter Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.4.1.8. Other Diagnostic Devices
        • 5.4.1.8.1. Other Diagnostic Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Treatment Devices
    • 5.5.1. Treatment Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.5.1.1. Lenses
        • 5.5.1.1.1. Lenses Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 5.5.1.1.2. Bandage Lenses
          • 5.5.1.1.2.1. Bandage Lenses Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
        • 5.5.1.1.3. Intraocular Lenses
          • 5.5.1.1.3.1. Intraocular Lenses Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.5.1.2. Laser Devices
        • 5.5.1.2.1. Laser Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 5.5.1.3. Other Treatment Devices
        • 5.5.1.3.1. Other Treatment Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Medications
    • 5.6.1. Medications Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.2. Antibiotics
      • 5.6.2.1. Antibiotics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.3. NSAIDs
      • 5.6.3.1. NSAIDs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.4. Corticosteroids
      • 5.6.4.1. Corticosteroids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.5. Lubricants / Artificial Tears
      • 5.6.5.1. Lubricants / Artificial Tears Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.6. Analgesics / Pain Relievers
      • 5.6.6.1. Analgesics / Pain Relievers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6.7. Other Medications
      • 5.6.7.1. Other Medications Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Veterinary Eye Care Market: By Indication Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Veterinary Eye Care Market: By Indication Movement Analysis
  • 6.3. U.S. Veterinary Eye Care Market Size & Trend Analysis, by Indication, 2021 to 2033 (USD Million)
    • 6.3.1. Eyelid Abnormalities
      • 6.3.1.1. Eyelid Abnormalities Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. Cataract
      • 6.3.2.1. Cataract Care Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. Glaucoma
      • 6.3.3.1. Glaucoma Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.3.3.2. Retinal Complications
      • 6.3.3.3. Retinal Complications Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.4. Uveitis
      • 6.3.4.1. Uveitis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.5. Conjunctivitis
      • 6.3.5.1. Conjunctivitis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.6. Corneal Complications
      • 6.3.6.1. Corneal Complications Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 6.3.7. Other Indications
      • 6.3.7.1. Other Indications Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Veterinary Eye Care Market: By Distribution Channel Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Veterinary Eye Care Market: By Distribution Channel Movement Analysis
  • 7.3. U.S. Veterinary Eye Care Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
    • 7.3.1. Veterinary Hospitals & Clinics
      • 7.3.1.1. Veterinary Hospitals & Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. Specialty Stores
      • 7.3.2.1. Specialty Stores Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. E-Commerce
      • 7.3.3.1. E-Commerce Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Other Distribution Channels
      • 7.3.4.1. Other Distribution Channels Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Company Market Position Analysis/ Heat Map Analysis
  • 8.3. Company Profiles
    • 8.3.1. Merck & Co., Inc.
      • 8.3.1.1. Participant's Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Product Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. An-Vision GmbH
      • 8.3.2.1. Participant's Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Product Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Jorgensen Laboratories
      • 8.3.3.1. Participant's Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Product Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. LKC Technologies Inc.
      • 8.3.4.1. Participant's Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Product Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Accutome Inc.
      • 8.3.5.1. Participant's Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Product Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Dechra
      • 8.3.6.1. Participant's Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Product Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Bausch & Lomb Incorporated
      • 8.3.7.1. Participant's Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Product Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Zoetis Services LLC.
      • 8.3.8.1. Participant's Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Product Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. Ceva Sante Animale
      • 8.3.9.1. Participant's Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Product Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. Sandoz
      • 8.3.10.1. Participant's Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Product Benchmarking
      • 8.3.10.4. Strategic Initiatives
    • 8.3.11. Boehringer Ingelheim
      • 8.3.11.1. Participant's Overview
      • 8.3.11.2. Financial Performance
      • 8.3.11.3. Product Benchmarking
      • 8.3.11.4. Strategic Initiatives
    • 8.3.12. I-Med Animal Health
      • 8.3.12.1. Participant's Overview
      • 8.3.12.2. Financial Performance
      • 8.3.12.3. Product Benchmarking
      • 8.3.12.4. Strategic Initiatives
    • 8.3.13. Iridex Corporation
      • 8.3.13.1. Participant's Overview
      • 8.3.13.2. Financial Performance
      • 8.3.13.3. Product Benchmarking
      • 8.3.13.4. Strategic Initiatives
    • 8.3.14. Baxter (Welch Allyn)
      • 8.3.14.1. Participant's Overview
      • 8.3.14.2. Financial Performance
      • 8.3.14.3. Product Benchmarking
      • 8.3.14.4. Strategic Initiatives
    • 8.3.15. OptoMed
      • 8.3.15.1. Participant's Overview
      • 8.3.15.2. Financial Performance
      • 8.3.15.3. Product Benchmarking
      • 8.3.15.4. Strategic Initiatives
    • 8.3.16. Reichert, Inc.
      • 8.3.16.1. Participant's Overview
      • 8.3.16.2. Financial Performance
      • 8.3.16.3. Product Benchmarking
      • 8.3.16.4. Strategic Initiatives
    • 8.3.17. Occuity
      • 8.3.17.1. Participant's Overview
      • 8.3.17.2. Financial Performance
      • 8.3.17.3. Product Benchmarking
      • 8.3.17.4. Strategic Initiatives
    • 8.3.18. Strategy Mapping
    • 8.3.19. Mergers & Acquisitions
    • 8.3.20. Partnerships & Collaborations
    • 8.3.21. Product launch
    • 8.3.22. Others
  • 8.4. List of other key players

List of Tables

  • Table 1 List of secondary sources
  • Table 2 U.S. Veterinary Eye Care Market, by Animal, 2021 - 2033 (USD Million)
  • Table 3 U.S. Veterinary Eye Care Market, by Product, 2021 - 2033 (USD Million)
  • Table 4 U.S. Veterinary Eye Care Market, by Indication, 2021 - 2033 (USD Million)
  • Table 5 U.S. Veterinary Eye Care Market, by Distribution Channel, 2021 - 2033 (USD Million)
  • Table 6 Company Overview
  • Table 7 Product Benchmarking
  • Table 8 Financial Performance
  • Table 9 Strategic Initiatives

List of Figures

  • Fig. 1 Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 U.S. Veterinary Eye Care Market revenue, 2021 - 2033 (USD Million)
  • Fig. 10 U.S. Veterinary Eye Care Market snapshot
  • Fig. 11 U.S. Veterinary Eye Care Market driver impact
  • Fig. 12 U.S. Veterinary Eye Care Market restraint impact
  • Fig. 13 Veterinary Eye Care animal key takeaways (USD Million)
  • Fig. 14 U.S. Veterinary Eye Care Market: animal, market share 2024 & 2033
  • Fig. 15 Canine market, 2021 - 2033 (USD Million)
  • Fig. 16 Feline market, 2021 - 2033 (USD Million)
  • Fig. 17 Equine market, 2021 - 2033 (USD Million)
  • Fig. 18 Bovine market, 2021 - 2033 (USD Million)
  • Fig. 19 Other Animals market, 2021 - 2033 (USD Million)
  • Fig. 20 U.S. Veterinary Eye Care Market Product key takeaways (USD Million)
  • Fig. 21 U.S. Veterinary Eye Care Market: Product, market share 2024 & 2033
  • Fig. 22 Devices & Instruments market, 2021 - 2033 (USD Million)
  • Fig. 23 Diagnostic Devices market, 2021 - 2033 (USD Million)
  • Fig. 24 Tonometers market, 2021 - 2033 (USD Million)
  • Fig. 25 Ophthalmic Test Kits market, 2021 - 2033 (USD Million)
  • Fig. 26 Electroretinogram (ERG) market, 2021 - 2033 (USD Million)
  • Fig. 27 Fundus Camera market, 2021 - 2033 (USD Million)
  • Fig. 28 Ophthalmoscopes market, 2021 - 2033 (USD Million)
  • Fig. 29 Pachymeter market, 2021 - 2033 (USD Million)
  • Fig. 30 Other Diagnostic Devices market, 2021 - 2033 (USD Million)
  • Fig. 31 Treatment Devices market, 2021 - 2033 (USD Million)
  • Fig. 32 Lenses market, 2021 - 2033 (USD Million)
  • Fig. 33 Bandage Lenses market, 2021 - 2033 (USD Million)
  • Fig. 34 Intraocular Lenses market, 2021 - 2033 (USD Million)
  • Fig. 35 Laser Devices market, 2021 - 2033 (USD Million)
  • Fig. 36 Other Treatment Devices market, 2021 - 2033 (USD Million)
  • Fig. 37 Medications market, 2021 - 2033 (USD Million)
  • Fig. 38 Antibiotics market, 2021 - 2033 (USD Million)
  • Fig. 39 NSAIDs market, 2021 - 2033 (USD Million)
  • Fig. 40 Corticosteroids market, 2021 - 2033 (USD Million)
  • Fig. 41 Lubricants / Artificial Tears market, 2021 - 2033 (USD Million)
  • Fig. 42 Analgesics / Pain Relievers market, 2021 - 2033 (USD Million)
  • Fig. 43 Other Medications market, 2021 - 2033 (USD Million)
  • Fig. 44 Veterinary Eye Care market by Indication: Key takeaways
  • Fig. 45 Veterinary Eye Care market by Indication, market share, 2024 & 2033
  • Fig. 46 Eyelid Abnormalities market, 2021 - 2033 (USD Million)
  • Fig. 47 Cataract market, 2021 - 2033 (USD Million)
  • Fig. 48 Glaucoma market, 2021 - 2033 (USD Million)
  • Fig. 49 Retinal Complications market, 2021 - 2033 (USD Million)
  • Fig. 50 Uveitis market, 2021 - 2033 (USD Million)
  • Fig. 51 Conjunctivitis market, 2021 - 2033 (USD Million)
  • Fig. 52 Corneal Complications market, 2021 - 2033 (USD Million)
  • Fig. 53 Other Indications market, 2021 - 2033 (USD Million)
  • Fig. 54 Veterinary Eye Care market by Distribution Channel: Key takeaways
  • Fig. 55 Veterinary Eye Care market by Distribution Channel, market share, 2024 & 2033
  • Fig. 56 Veterinary Hospitals & Clinics market, 2021 - 2033 (USD Million)
  • Fig. 57 Specialty Stores market, 2021 - 2033 (USD Million)
  • Fig. 58 E-Commerce market, 2021 - 2033 (USD Million)
  • Fig. 59 Other Distribution Channels market, 2021 - 2033 (USD Million)
  • Fig. 60 Market participant categorization